A detailed history of Russell Investments Group, Ltd. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 984 shares of PCRX stock, worth $19,158. This represents 0.0% of its overall portfolio holdings.

Number of Shares
984
Previous 55,495 98.23%
Holding current value
$19,158
Previous $1.59 Million 99.12%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$11.7 - $28.46 $637,778 - $1.55 Million
-54,511 Reduced 98.23%
984 $14,000
Q2 2024

Aug 08, 2024

SELL
$25.5 - $31.51 $115,693 - $142,960
-4,537 Reduced 7.56%
55,495 $1.59 Million
Q1 2024

May 08, 2024

SELL
$27.7 - $35.48 $4.6 Million - $5.9 Million
-166,241 Reduced 73.47%
60,032 $1.75 Million
Q4 2023

Feb 05, 2024

SELL
$26.32 - $34.31 $3.26 Million - $4.25 Million
-123,756 Reduced 35.36%
226,273 $7.63 Million
Q3 2023

Nov 13, 2023

BUY
$30.68 - $40.09 $4.77 Million - $6.23 Million
155,394 Added 79.84%
350,029 $10.7 Million
Q2 2023

Aug 10, 2023

SELL
$36.12 - $47.5 $3.94 Million - $5.18 Million
-109,152 Reduced 35.93%
194,635 $7.8 Million
Q1 2023

May 09, 2023

SELL
$35.53 - $43.38 $962,045 - $1.17 Million
-27,077 Reduced 8.18%
303,787 $12.4 Million
Q4 2022

Feb 08, 2023

SELL
$38.19 - $57.45 $6.26 Million - $9.41 Million
-163,864 Reduced 33.12%
330,864 $12.8 Million
Q3 2022

Nov 04, 2022

BUY
$51.24 - $58.89 $1.99 Million - $2.29 Million
38,888 Added 8.53%
494,728 $26.3 Million
Q2 2022

Jul 29, 2022

BUY
$51.49 - $81.64 $8.38 Million - $13.3 Million
162,736 Added 55.52%
455,840 $26.6 Million
Q1 2022

May 05, 2022

BUY
$60.03 - $76.49 $9.71 Million - $12.4 Million
161,757 Added 123.15%
293,104 $22.4 Million
Q4 2021

Jan 21, 2022

BUY
$47.97 - $62.21 $6.14 Million - $7.96 Million
127,924 Added 3737.19%
131,347 $7.9 Million
Q3 2021

Nov 08, 2021

BUY
$54.64 - $61.3 $53,274 - $59,767
975 Added 39.83%
3,423 $191,000
Q1 2021

May 10, 2021

BUY
$59.31 - $78.82 $145,190 - $192,951
2,448 New
2,448 $171,000
Q4 2020

Feb 08, 2021

SELL
$50.47 - $66.26 $193,199 - $253,643
-3,828 Closed
0 $0
Q3 2020

Nov 09, 2020

SELL
$51.97 - $63.0 $3.35 Million - $4.06 Million
-64,393 Reduced 94.39%
3,828 $230,000
Q2 2020

Aug 05, 2020

BUY
$30.8 - $52.47 $8,747 - $14,901
284 Added 0.42%
68,221 $3.58 Million
Q1 2020

May 06, 2020

BUY
$28.4 - $50.7 $1.54 Million - $2.74 Million
54,140 Added 392.4%
67,937 $2.28 Million
Q4 2019

Jan 29, 2020

BUY
$36.31 - $46.83 $106,606 - $137,492
2,936 Added 27.03%
13,797 $623,000
Q3 2019

Nov 01, 2019

SELL
$35.66 - $44.99 $394,221 - $497,364
-11,055 Reduced 50.44%
10,861 $414,000
Q2 2019

Aug 09, 2019

SELL
$36.57 - $47.97 $2.87 Million - $3.76 Million
-78,442 Reduced 78.16%
21,916 $953,000
Q1 2019

May 13, 2019

SELL
$36.47 - $42.17 $1.88 Million - $2.17 Million
-51,518 Reduced 33.92%
100,358 $3.82 Million
Q4 2018

Feb 11, 2019

BUY
$41.31 - $52.16 $3.77 Million - $4.75 Million
91,161 Added 150.15%
151,876 $6.53 Million
Q3 2018

Oct 26, 2018

BUY
$32.85 - $52.0 $134,849 - $213,460
4,105 Added 7.25%
60,715 $2.97 Million
Q2 2018

Aug 08, 2018

BUY
$27.5 - $39.8 $199,347 - $288,510
7,249 Added 14.69%
56,610 $1.81 Million
Q1 2018

May 11, 2018

BUY
$29.98 - $46.35 $570,549 - $882,086
19,031 Added 62.75%
49,361 $1.54 Million
Q4 2017

Feb 06, 2018

BUY
$31.85 - $46.95 $167,945 - $247,567
5,273 Added 21.04%
30,330 $1.38 Million
Q3 2017

Nov 07, 2017

BUY
$35.7 - $39.5 $894,534 - $989,751
25,057
25,057 $940,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.